Expert Interviews

David Cherney, MD: SGLT2 Inhibitors and Prescribing Responsibility

September 28, 2020

An associate professor from University of Toronto discusses whose responsibility it is to prescribe SGLT2 inhibitors to patients.

Matthew Budoff, MD: Clinical Usefulness of CAC Scores

September 11, 2020

An interview examining the use of coronary artery calcium scores for predicting CV events and stroke risk in real-world settings.

Diana Isaacs, PharmD: An Overview of Insulin Affordability in 2020

September 01, 2020

A look at the state of insulin affordability in 2020 and how the ongoing pandemic has impacted the situation.

Managing Hyperglycemia in COVID-19

August 17, 2020

A professor from Michigan Medicine discusses recent research from the institute and how protocols implemented at Michigan Medicine to manage the increased risk of severe outcomes associated with hyperglycemia in COVID-19.

Daniel Spratt, MD: Estrogen, Birth Control, and COVID-19 Clotting Risk

August 04, 2020

A practicing endocrinologist and professor of medicine offers insight into the potential for increase in risk of blood clots in certain groups of women if they were to contract COVID-19.

Video: When Should Metformin be Omitted?

November 10, 2017

Guidelines say metformin should be stopped where there is acute kidney injury or risk of renal compromise. Now there is evidence to support those recommendations.

Diabetes Self-Management: Nurse-Led Approach

May 17, 2017

Patients were randomized to standard care, nurse-led education intervention, or nurse-led education plus acceptance therapy.

Renal Effects: SGLT2 Inhibitors in Type 2 Diabetes

April 21, 2017

A meta-analysis compared the renal side effects of SGLT2 inhibitors in patients with type 2 diabetes.

CV Events: Safety of Insulin

April 14, 2017

A study compared mortality and major adverse cardiovascular events in patients with type 2 diabetes prescribed metformin or insulin.

Can Liraglutide Delay Diabetes Onset?

March 31, 2017

Researchers compared time to onset of diabetes in a group of patients with obesity and pre-diabetes treated with liraglutide or placebo.

Dapagliflozin: All-Cause & Cardiovascular Mortality

March 20, 2017

Research has shown the beneficial effects of empagliflozin on all-cause and CV mortality. Does the same hold true for another SGLT2 inhibitor?

Combo Therapy vs Insulin: Type 2 Diabetes

March 09, 2017

The Qatar Study investigated the efficacy of exenatide plus pioglitazone versus basal-bolus insulin in poorly-controlled type 2 diabetes.

Type 1 Diabetes and the Microbiome

February 20, 2017

The authors compared biopsies of the duodenal mucosa in patients with type 1 diabetes, celiac disease, and controls.

Thyroid Dysfunction: Relation to Radiation Dose

February 08, 2017

Researchers examined the correlation between radiation dose for head and neck cancer and subsequent thyroid dysfunction.

Diabetes & Ethnicity: Potential Life Years Lost

January 19, 2017

What role, if any, does ethnicity play in potential life years lost in patients with diabetes?

Psilocybin to Manage Cancer-Related Depression

December 21, 2016

Dr. Bobby Lazzara reviews a small study testing the effects of psilocybin on depression and anxiety in patients with life-threatening cancer.

Diabetes Incidence: State-by-State

December 18, 2016

The incidence of diabetes in the US continues to grow – 11.5% in 2016. Dr. Lazzara looks at a state-by-state breakdown.

Statin Therapy with Type 2 Diabetes & Nephropathy

December 08, 2016

In patients with type 2 diabetes complicated by nephropathy, what is the real life effect of statin therapy on cardiovascular disease prevention?

Chocolate and Type 2 Diabetes: a Healthy Habit?

November 30, 2016

Compounds in cocoa and chocolate have known cardiovascular benefits. Could habitual chocolate intake lower the risk of type 2 diabetes as well?

CV Risks and Diabetes: Puerto Rican Population

October 28, 2016

Dr. Bobby Lazzara discusses a study looking at certain demographics and cardiovascular complications in a diabetic patient population in Puerto Rico.